Simulations Plus (NASDAQ:SLP – Get Rating)‘s stock had its “outperform” rating reissued by equities researchers at Oppenheimer in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $65.00 price target on the technology company’s stock. Oppenheimer’s price target suggests a potential upside of 53.66% from the stock’s previous close. Oppenheimer also issued estimates for Simulations Plus’ FY2023 earnings at $0.66 EPS.
Separately, StockNews.com began coverage on shares of Simulations Plus in a report on Thursday, March 16th. They set a “hold” rating for the company. One analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, Simulations Plus currently has a consensus rating of “Moderate Buy” and an average price target of $63.67.
Simulations Plus Price Performance
SLP stock opened at $42.30 on Thursday. Simulations Plus has a 1-year low of $32.58 and a 1-year high of $67.59. The firm has a fifty day moving average price of $40.85 and a two-hundred day moving average price of $41.59. The firm has a market cap of $859.96 million, a price-to-earnings ratio of 81.35 and a beta of 0.54.
Insider Buying and Selling
In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Friday, February 24th. The shares were sold at an average price of $38.04, for a total value of $760,800.00. Following the sale, the director now directly owns 3,915,739 shares in the company, valued at $148,954,711.56. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Friday, February 24th. The stock was sold at an average price of $38.04, for a total transaction of $760,800.00. Following the sale, the director now owns 3,915,739 shares in the company, valued at approximately $148,954,711.56. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Walter S. Woltosz sold 2,258 shares of the business’s stock in a transaction dated Monday, January 30th. The stock was sold at an average price of $39.74, for a total value of $89,732.92. Following the sale, the director now owns 3,935,010 shares in the company, valued at approximately $156,377,297.40. The disclosure for this sale can be found here. Insiders sold 76,352 shares of company stock valued at $3,038,026 over the last 90 days. 21.30% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Simulations Plus
Large investors have recently made changes to their positions in the business. Rhumbline Advisers grew its position in shares of Simulations Plus by 0.5% in the first quarter. Rhumbline Advisers now owns 59,693 shares of the technology company’s stock valued at $3,043,000 after purchasing an additional 279 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Simulations Plus by 0.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 51,715 shares of the technology company’s stock valued at $2,551,000 after buying an additional 284 shares during the last quarter. Yousif Capital Management LLC increased its position in Simulations Plus by 3.0% in the 1st quarter. Yousif Capital Management LLC now owns 13,810 shares of the technology company’s stock worth $704,000 after buying an additional 400 shares during the period. Principal Financial Group Inc. lifted its holdings in shares of Simulations Plus by 0.5% during the fourth quarter. Principal Financial Group Inc. now owns 102,287 shares of the technology company’s stock worth $3,741,000 after buying an additional 531 shares during the last quarter. Finally, Ensign Peak Advisors Inc boosted its position in shares of Simulations Plus by 0.6% in the first quarter. Ensign Peak Advisors Inc now owns 103,475 shares of the technology company’s stock valued at $5,275,000 after acquiring an additional 590 shares during the period. Institutional investors and hedge funds own 74.27% of the company’s stock.
Simulations Plus Company Profile
Simulations Plus, Inc provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The firm operates through the Software and Services segment. It designs and develops pharmaceutical simulation software to promote cost-effective solutions to a number of problems in pharmaceutical research and in the education of pharmacy and medical students.
Further Reading
- Get a free copy of the StockNews.com research report on Simulations Plus (SLP)
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here’s Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
- FedEx Takes Flight; Analysts See More Gains Ahead
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
